Pennsylvania Folklife Vol. 25, No. 1

• Pennsylvania German Tombstone Art of Lebanon County, Pennsylvania • Rain Day in Waynesburg, Pennsylvania • Non-Ordinary Stoneware Pieces from New Geneva and Greensboro, Pennsylvania • Pennsylvania German Astronomy and Astrology XIII: Conjunctions of 1683, 1694, and 1743 • The Social Context of Musical Instruments within the Pennsylvania German Culture • Tourism and the Amish Way of Life • Home Brewing Techniques: Folk-Cultural Questionnaire No. 41https://digitalcommons.ursinus.edu/pafolklifemag/1065/thumbnail.jp

Case and Activity Identification for Mining Process Models from Middleware

Process monitoring aims to provide transparency over operational aspects of a business process. In practice, it is a challenge that traces of business process executions span across a number of diverse systems. It is cumbersome manual engineering work to identify which attributes in unstructured event data can serve as case and activity identifiers for extracting and monitoring the business process. Approaches from literature assume that these identifiers are known a priori and data is readily available in formats like eXtensible Event Stream (XES). However, in practice this is hardly the case, specifically when event data from different sources are pooled together in event stores. In this paper, we address this research gap by inferring potential case and activity identifiers in a provenance agnostic way. More specifically, we propose a semi-automatic technique for discovering event relations that are semantically relevant for business process monitoring. The results are evaluated in an industry case study with an international telecommunication provider

Multi-instance mining:discovering synchronisation in artifact-centric processes

\u3cp\u3eIn complex systems one can often identify various entities or artifacts. The lifecycles of these artifacts and the loosely coupled interactions between them define the system behavior. The analysis of such artifact system behavior with traditional process discovery techniques is often problematic due to the existence of many-to-many relationships between artifacts, resulting in models that are difficult to understand and statistics that are inaccurate. The aim of this work is to address these issues and enable the calculation of statistics regarding the synchronisation of behaviour between artifact instances. By using a Petri net formalisation with step sequence execution semantics to support true concurrency, we create state-based artifact lifecycle models that support many-to-many relations between artifacts. The approach has been implemented as an interactive visualisation in ProM and evaluated using real-life public data.\u3c/p\u3

Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018)

© 2019 Consilium Medikum. All rights reserved. The article is published based on the results of the Russian Consensus on the diagnosis and treatment of primary sclerosing cholangitis (PSC), discussed at the 44 th annual Scientific Session of the CNIIG "Personalized Medicine in the Era of Standards" (March 1, 2018). The aim of the review is to highlight the current issues of classification of diagnosis and treatment of patients with PSC, which causes the greatest interest of specialists. The urgency of the problem is determined by the multivariate nature of the clinical manifestations, by often asymptomatic flow, severe prognosis, complexity of diagnosis and insufficient study of PSC, the natural course of which in some cases can be considered as a function with many variables in terms of the nature and speed of progression with numerous possible clinical outcomes. In addition to progression to portal hypertension, cirrhosis and its complications, PSC can be accompanied by clinical manifestations of obstructive jaundice, bacterial cholangitis, cholangiocarcinoma and colorectal cancer. Magnetic resonance cholangiography is the main method of radial diagnostics of PSC, which allows to obtain an image of bile ducts in an un-invasive way. The use of liver biopsy is best justified when there is a suspicion of small-diameter PSC, autoimmune cross-syndrome PSC-AIG, IgG4-sclerosing cholangitis. Currently, a drug registered to treat primary sclerosing cholangitis which can significantly change the course and prognosis of the disease does not exist. There is no unified view on the effectiveness and usefulness of ursodeoxycholic acid and its dosage in PSC. Early diagnosis and determination of the phenotype of PSC is of clinical importance. It allows to determine the tactics of treatment, detection and prevention of complications

Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018)

© 2019 Consilium Medikum. All rights reserved. The article is published based on the results of the Russian Consensus on the diagnosis and treatment of primary sclerosing cholangitis (PSC), discussed at the 44 th annual Scientific Session of the CNIIG "Personalized Medicine in the Era of Standards" (March 1, 2018). The aim of the review is to highlight the current issues of classification of diagnosis and treatment of patients with PSC, which causes the greatest interest of specialists. The urgency of the problem is determined by the multivariate nature of the clinical manifestations, by often asymptomatic flow, severe prognosis, complexity of diagnosis and insufficient study of PSC, the natural course of which in some cases can be considered as a function with many variables in terms of the nature and speed of progression with numerous possible clinical outcomes. In addition to progression to portal hypertension, cirrhosis and its complications, PSC can be accompanied by clinical manifestations of obstructive jaundice, bacterial cholangitis, cholangiocarcinoma and colorectal cancer. Magnetic resonance cholangiography is the main method of radial diagnostics of PSC, which allows to obtain an image of bile ducts in an un-invasive way. The use of liver biopsy is best justified when there is a suspicion of small-diameter PSC, autoimmune cross-syndrome PSC-AIG, IgG4-sclerosing cholangitis. Currently, a drug registered to treat primary sclerosing cholangitis which can significantly change the course and prognosis of the disease does not exist. There is no unified view on the effectiveness and usefulness of ursodeoxycholic acid and its dosage in PSC. Early diagnosis and determination of the phenotype of PSC is of clinical importance. It allows to determine the tactics of treatment, detection and prevention of complications